NeuBase Therapeutics Inc Shares Fall 1.2% Below Previous 52-Week Low - Market Mover

The shares fell 1.2% lower than its previous 52-week low of $6.58, with trading volume lower than its 30 day average

Apr 06, 2021 by Kwhen Finance Editors

NeuBase Therapeutics Inc Shares Fall 1.2% Below Previous 52-Week Low - Market Mover
NeuBase Therapeutics Inc shares closed 1.2% lower than its previous 52 week low, giving the company a market cap of $155M. The stock is currently down 4.1% year-to-date, down 7.6% over the past 12 months, and down 90.6% over the past five years. This week, the Dow Jones Industrial Average rose 1.3%, and the S&P 500 rose 2.6%.

Trading Activity

  • Trading volume this week was 56.3% higher than the 20-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
  • The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
NeuBase Therapeutics Inc-3.0-4.1-7.6-47.03.8
Dow Jones Industrial Average0.29.850.5-0.649.2
S&P 500 Index0.59.155.80.252.7
Health Care0.42.632.5-2.429.6

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by -108.6%
  • The company's stock price performance over the past 12 months lags the peer average by -107.1%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
NeuBase Therapeutics IncNBSE0-4.1-7.6-47.03.8
Peer AvgN/A048.0107.5-26.6191.5
Ocular Therapeutix IncOCUL0-17.5239.6-29.1262.2
OncoCyte CorpOCX0118.4139.4-18.6365.2
Oragenics Inc.OGEN090.950.8-58.9138.6

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: